Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
12/2010
12/02/2010WO2010137877A2 Plant stem cell derived from cambium of family asteraceae and method for the isolated culturing thereof
12/02/2010WO2010137746A1 Method for producing induced pluripotent stem cells and method for culturing the same
12/02/2010WO2010137744A1 New marker for detection of induced pluripotent stem cell
12/02/2010WO2010137722A1 Method for screening of regenerative medicine
12/02/2010WO2010137547A1 Pharmaceutical composition containing nuclear factor involved in proliferation and differentiation of central neuronal cells
12/02/2010WO2010137489A1 Glucose dehydrogenase having altered properties
12/02/2010WO2010137348A1 Method for selecting clone of induced pluripotent stem cells
12/02/2010WO2010137295A1 Cdc45l peptides and vaccines including the same
12/02/2010WO2010136877A1 Muteins of the pyrroline-5-carboxylate reductase 1
12/02/2010WO2010136752A1 Neural differentiation medium
12/02/2010WO2010136515A1 Method for a rational cell culturing process
12/02/2010WO2010136508A2 Stem cell targeting
12/02/2010WO2010136136A2 Method for producing a coated cell culture carrier
12/02/2010WO2010135813A1 Increased seed oil and abiotic stress tolerance mediated by hsi2
12/02/2010WO2010117301A3 Method for producing pluripotential cells
12/02/2010WO2010088633A4 Novel cell lines and methods
12/02/2010WO2010088230A3 Adult stem cell assays
12/02/2010WO2010068923A3 Agents that selectively inhibit cd25 on dendritic cells or t cells and their use
12/02/2010WO2010057039A3 Encapsulation of pancreatic cells derived from human pluripotent stem cells
12/02/2010WO2009095600A3 Novel cellular growth factor of non-animal origin and applications
12/02/2010US20100306882 Production of hybrid lactuca sativa seeds
12/02/2010US20100306881 improved ability to enzymatically degrade lignocellulosic feedstock; fermentation
12/02/2010US20100306880 Nucleic acids for inducing expression of transcripts and proteins and methods for making and using them
12/02/2010US20100306879 Polypeptides having cellobiohydrolase activity and polynucleotides encoding same
12/02/2010US20100306876 Meg1 endosperm-specific promoters and genes
12/02/2010US20100306875 Resistance gene and uses thereof
12/02/2010US20100306873 Nucleotide sequences and corresponding polypeptides conferring modulated growth rate and biomass in plants grown in saline conditions
12/02/2010US20100306871 Plants and seeds of hybrid corn variety ch293284
12/02/2010US20100306869 Modulating production traits in avians
12/02/2010US20100306868 Quadruple transgenic non-human animal
12/02/2010US20100306864 Polypeptide having enhanced effector function
12/02/2010US20100306863 Screening, therapy and diagnosis
12/02/2010US20100306862 Non-human animal model for frontotemporal lobar degeneration with ubiquitin-positive inclusions (ftld-u)
12/02/2010US20100305696 Hybrid soft tissue implants from progenitor cells and biomaterials
12/02/2010US20100305306 Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
12/02/2010US20100305214 Use of a Monoterpene to Increase Tissue Repair
12/02/2010US20100305201 Method of Treating a Tumor and Biodistribution of a Drug Delivered by Worm-Like Filomicelles
12/02/2010US20100305198 Cationic lipids
12/02/2010US20100305197 Conditionally Active Ribozymes And Uses Thereof
12/02/2010US20100305195 microrna mediator of cardiomyopathy and heart failure
12/02/2010US20100305194 Modified and stabilized gdf propeptides and uses thereof
12/02/2010US20100305192 Compositions and methods for short interfering nucleic acid inhibition of nav1.8
12/02/2010US20100305190 Nucleic acid complex and nucleic acid delivery composition
12/02/2010US20100305186 Methods for mediating gene suppression
12/02/2010US20100305136 Quinolone analogs derivatized with sulfonic acid, sulfonate or sulfonamide
12/02/2010US20100305121 Novel antagonists of the human fatty acid synthase thioesterase
12/02/2010US20100305106 Inhibitors of fatty acid uptake and methods of use
12/02/2010US20100305105 Phenylsulfoxyoxazole compound inhibitors of urea transporters
12/02/2010US20100305083 Substituted porphyrins
12/02/2010US20100305051 Natriuretic activities
12/02/2010US20100305040 Production of soluble recombinant protein by pi value control of n-terminal
12/02/2010US20100305039 Production of collagen in the milk of transgenic mammals
12/02/2010US20100305034 Growth factor isoform
12/02/2010US20100305024 Methods of inhibiting calcineurin with apoe analogs
12/02/2010US20100305003 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
12/02/2010US20100305001 Functional assay for indentification of loss-of-function mutations in genes
12/02/2010US20100304489 Methods and compositions for homologous recombination in human cells
12/02/2010US20100304488 Regeneration and mass propagation of jatropha curcas through somatic embryogenesis
12/02/2010US20100304487 Soft tissue processing
12/02/2010US20100304486 Methods of generating embryoid bodies and uses of same
12/02/2010US20100304485 Cell rolling separation
12/02/2010US20100304484 Use of Alginate Matrices to Control Cell Growth
12/02/2010US20100304483 T-cell vaccination in the treatment of hiv infection
12/02/2010US20100304482 Swellable synthetic microcarriers for culturing cells
12/02/2010US20100304481 Medium and culture of embryonic stem cells
12/02/2010US20100304480 Hematopoietic Fingerprints: Methods of Use
12/02/2010US20100304479 Method of making a hair and biological material
12/02/2010US20100304478 Method for isolating renal stem/progenitor cells, renal stem/progenitor cells and therapeutic agent for renal disease
12/02/2010US20100304477 Population of adult stem cells derived from cardiac adipose tissue and use thereof in cardiac regeneration
12/02/2010US20100304436 Fucosylation-Deficient Cells
12/02/2010US20100304434 Polypeptides having Cellulolytic Enhancing Activity and Polynucleotides Encoding Same
12/02/2010US20100304428 Cell holding method, cell testing method and cell handling apparatus
12/02/2010US20100304389 Preparation And Isolation of 5' Capped mRNA
12/02/2010US20100304382 Gene Defects and Mutant ALK Kinase in Human Solid Tumors
12/02/2010US20100304370 Intracellular ph sensor using nucleic acid assemblies
12/02/2010US20100303899 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
12/02/2010US20100303897 Novel addl receptor polypeptides, polynucleotides and host cells for recombinant production
12/02/2010US20100303888 Composition for enhancing bone formation
12/02/2010US20100303884 Growth factor complexes and modulation of cell migration and growth
12/02/2010US20100303871 Compositions and methods for modulating cellular membrane-mediated intracellular signal transduction
12/02/2010US20100303868 Ex vivo, fast and efficient process to obtain activated antigen-presenting cells that are useful for therapies against cancer and immune system-related diseases
12/02/2010US20100303866 Immunogenic peptides and their use in immune disorders
12/02/2010US20100303859 Vectors and method for genetic immunization
12/02/2010US20100303858 Chimeric HIV-1 Glycoproteins and Their Biological Applications
12/02/2010US20100303856 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva)
12/02/2010US20100303839 Methods and compositions for treatment of cancer using oncolytic rsv activity
12/02/2010US20100303838 Vectors for multiple gene expression
12/02/2010US20100303837 Carbohydrate specific cellular immunity inducing microorganisms and fractions thereof
12/02/2010US20100303835 Peptoid ligands for isolation and treatment of autoimmune t-cells
12/02/2010US20100303834 Compositions and methods for the diagnosis and treatment of tumor
12/02/2010US20100303833 Method for Identifying a MHC Class H-Dependent Tumor Associated T Helper Cell Antigen
12/02/2010US20100303829 Hiv vpr-specific t cell receptors
12/02/2010US20100303828 Antibodies Against Human CD39 and Use Thereof for Inhibiting T Regulatory Cells Activity
12/02/2010US20100303825 Anti-estrogen and immune modulator combinations for treating breast cancer
12/02/2010US20100303821 Immunoglobulins
12/02/2010US20100303820 Methods of treatment using il-17e antagonists
12/02/2010US20100303819 Dcl-1 and uses thereof
12/02/2010US20100303818 Dendritic cell receptor
12/02/2010US20100303817 Antibodies to treat cancer
12/02/2010US20100303816 Antibodies against human melanoma-associated chondroitin sulphate proteoglycan (mcsp)
1 ... 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 ... 1827